Introduction
Structural abnormalities involving 11q23 are among the most common cytogenetic abnormalities in patients with acute leukemia. Most of these abnormalities involve the MLL gene, which is also known as ALL-1, HRX, and HTRX1. [1] [2] [3] [4] At least 40 different partner chromosomes have been involved in 11q23 translocations. [5] [6] [7] [8] [9] [10] [11] [12] To date, 13 genes involved in translocations with MLL have been cloned. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] It has been suggested that alteration of the MLL protein is the critical event in oncogenesis and that fusion partners may not play an important role in the oncogenic process. 26, 27 MLL gene rearrangements are associated with acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and secondary acute leukemias. 2, [28] [29] [30] [31] Approximately 70% of infants and 6% of older children with ALL have cytogenetic abnormalities at 11q23. This chromosomal abnormality is also seen in nearly 40% of infants and 15% of older children with AML. [32] [33] [34] [35] Infants and older children with ALL and with MLL gene rearrangements have an extremely poor outcome. 29, [36] [37] [38] [39] The prognostic impact of 11q23 abnormalities and MLL gene rearrangement in children with AML remains controversial. 35, [40] [41] [42] [43] Abnormalities at 11q23 are usually detected by conventional cytogenetics, whereas rearrangements of the MLL gene are typically evaluated by Southern blotting, 10, 41, 44 fluorescence in situ hybridization (FISH), [45] [46] [47] and reverse transcriptase-polymerase chain reaction (RT-PCR). 48 Given the diversity of the MLL gene abnormalities, methods for detecting MLL gene rearrangements need to be chosen with care. Poirel et al 49 49 supported the limited use of FISH and recommended RT-PCR as the best method for detecting MLL rearrangements. However, Hunger and Cleary 50 recommended that RT-PCR not be used alone as a screening method. This conclusion was drawn from the observation that MLL-AF4 transcripts were present in healthy individuals and that, in some cases, a t(4;11) detected by cytogenetic methods and Southern blotting was not found with RT-PCR. 28, [51] [52] [53] Unlike RT-PCR, Southern blotting does not require the prior knowledge of the partner gene involved in the translocation. Moreover, deletions, partial duplications and small changes in copy number can only be detected by more elaborate Southern blot analysis. However, the method is time-consuming and labor-intensive.
The aims of the present study were to determine whether MLL gene rearrangements in children with acute leukemia could be detected with the commercially available MLL probe (Oncor, Gaithersburg, MD, USA) and to determine the reliability and feasibility of FISH in assessing the MLL gene status in a clinical setting. For this, we examined bone marrow samples from 67 children with ALL or AML and with cytogenetic evidence of an 11q23 abnormality. We compared the results from the cytogenetic analyses with those from FISH and Southern blotting analyses. In most patients, MLL gene rearrangements were detected by both FISH and Southern blotting. FISH identified all but two cases shown by Southern blotting to have a rearranged MLL gene. Furthermore, FISH identified two novel chromosomal breakpoints, 1p22 and 16p11.2, that were involved in rearrangements with MLL. Also, the present study identified two new complex translocations involving the MLL gene, t(5;9;11)(q23;p22;q23) and t(7;9;11)(p15;p22;q23), in children with AML.
Materials and methods

Patients
Samples from 67 patients with 11q23 abnormalities were studied by three methods: cytogenetics, FISH, and Southern blotting. Of the 67 patients (33 males and 34 females), 42 had ALL and 25 had AML. The mean age was 6.3 years (range, newborn to 16.9 years). Other clinical features such as hyperleukocytosis, age at the time of diagnosis, and remission rate were not evaluated because these parameters had been previously studied.
29,30
Cytogenetic analysis
Leukemic cells from the bone marrow of each patient were subjected to cytogenetic analysis according to the protocol of Williams et al. 54 Karyotypes were described according to the International System for Human Cytogenetic Nomenclature. 55 
Fluorescence in situ hybridization
FISH was performed on methanol and acetic acid fixed cells kept at −20°C after cytogenetic analysis or on cells on cytospin slides. Slides were pretreated with 2 × SSC for 30 min and dehydrated through an ethanol series. The chromosomal DNA was denatured in 70% formamide, 2 × SSC at 70°C for 2 min and then dehydrated through a cold alcohol series. The commercially available MLL probe (digoxigenin labeled; Oncor) is a YAC clone that contains exons 4-11 of the MLL gene. However, the specific characteristics of the probe have not been reported. The probe was incubated at 37°C for 5 min, applied to the denatured chromosomes or interphase cells, and hybridized overnight at 37°C. After the overnight hybridization, sequential washings were done at 42°C to remove unbound nucleotides: four washes in 50% formamide for 5 min each, two washes in 2 × SSC for 5 min each, and two washes in phosphate-buffered detergent (PBD). The bound probe was detected by incubating the slide in rhodamine-labeled antidigoxigenin at 37°C for 30 min in a humidified chamber. The slides were washed with PBD three times for 2 min each and were stained with DAPI (4Ј, 6-, diamidine-2Ј-phenylindole dihydrochloride). When the signal intensity was weak, the signals were amplified according to the manufacturer's protocol. Analysis was done with an Olympus fluorescence microscope (Olympus America, Melville, NY, USA) attached to an imaging system (VYSIS, Downers Grove, IL, USA). When necessary, FISH with painting probes was performed to identify the partner chromosome involved in the MLL rearrangement.
A minimum of 200 interphase nuclei in each sample was counted by two trained persons. Overlapping nuclei were excluded from the analysis. The analyses of metaphase (when available) and interphase cells were performed according to the criteria described by Hopman et al. 56 Briefly, when the MLL probe hybridized with DNA in normal interphase cells, two signals were observed (Figure 1a ). Interphase cells that had an MLL gene rearrangement showed one normal signal and two smaller signals, ie a split signal, indicating that one of the homologs was split because of the translocation ( Figure  1b) . When one allele of the MLL gene was deleted, only one signal was observed (Figure 1c ). When trisomy of chromosome 11 was present, three signals of equal size were observed ( Figure 1d ).
To determine the specificity of the MLL probe in FISH, control experiments were performed on bone marrow samples 
Southern blot analysis
Genomic DNA from 67 patients was analyzed for MLL rearrangements as previously described. 29 Genomic DNA was extracted from leukemic blast cells of patients at the time of diagnosis, and/or at the time of relapse. Aliquots (5 to 10 g) of high molecular weight DNA were digested with BamHI, HindIII, and SacI. The restriction fragments were separated by electrophoresis in 0.8% agarose gels and were blotted on to nylon membranes by using standard Southern method. All blots were hybridized with a 32 P-labeled probe derived from a 0.74-kb BamHI cDNA fragment of the MLL gene. The probe detects the common breakpoints between exons 5 to 11 in BamHI-digested DNA and breaks centromeric to exon 5 and telomeric to exon 11 in HindIII-digested and SacI-digested DNA.
Results
Analysis of MLL gene in children with ALL
Cytogenetic analyses of the samples from 42 patients with ALL detected 29 translocations, one inversion, and 12 deletions affecting the 11q23 region. Of the 29 samples with translocations, 13 had a t(4;11), three had a t(9;11), and six had a t (11;19) . Other partners (four known and three unknown) were detected in seven patients. Samples from 40 patients were studied at the time of diagnosis, whereas samples from two patients were evaluated at the time of relapse. The results of cytogenetic, immunophenotypic, FISH, and Southern blot analyses are summarized in Table 1 . Of the 42 patients with ALL, eight had T cell ALL, and the rest had B-lineage ALL. Of the eight patients with T cell ALL, three had a t(11;19), one had a t(11;15), and four had deletions of the 11q23 region.
t(4;11)(q21;q23)
In all samples from the 13 patients with a t(4;11), both FISH and Southern analyses detected MLL gene rearrangements. No discrepancies in the findings obtained by these methods were noted.
t(9;11)(p22;q23)
In all the three cases with t(9;11), both FISH and Southern analyses identified a MLL gene rearrangement. For one of the samples, the initial cytogenetic analysis identified a deletion of 11q23, but FISH and Southern blotting detected a gene rearrangement. Subsequently, FISH using the painting probes for chromosomes 9 and 11 identified an insertion of chromosome 11 on the short arm of chromosome 9 ( Figure 2 ). The
Figure 2
Metaphase displaying the insertion of a segment of chromosome 11 on chromosome 9p identified by FISH. Chromosome 11 is hybridized with digoxigenin-labeled whole-chromosome painting probe (red), and chromosome 9 is hybridized with biotin-labeled whole chromosome painting probe (green). The arrow shows the insertion of chromosome 11 segment in 9p22. The MLL gene was also rearranged (not shown).
karyotype was rewritten as 46,XY,del(11)(q23). ish ins (9;11)(p22;q23q25)(wcp11+;wcp9−), nuc ish 11q23 (MLLx3). In another case, cytogenetic analysis performed at the time of diagnosis detected the translocation in only one cell even though all cells in the bone marrow aspirate were blast cells. However, FISH done retrospectively with cells on a cytospin slide detected a MLL gene rearrangement in 3.6% of patients' cells, which is above our lower limit of detection with this probe.
t(11;19)(q23;p13.3)
The t(11;19) was the sole abnormality in samples from three patients; in the three other patients with the t(11;19), additional random chromosomal aberrations were present. FISH and Southern blotting identified MLL rearrangements in all six samples, which were from patients with either B cell or T cell ALL.
t(11q23;variable) and inv(11)(p13q23)
Of the samples from seven patients in which the 11q23 band was associated with variable partner chromosomes, four of the translocations had known partners (1q32, 3p11, 14q32, and 15q15). Three had additional material on 11q23, but the partner chromosomes could not be identified.
FISH and Southern blot analysis detected the MLL gene rearrangement in only one [t(11;15)(q23;q15)] of the four samples in which the partner chromosomes were known. In the sample containing a t(3;11)(p11;q23), FISH detected a deletion of one of the alleles of the MLL gene, and Southern blotting analysis showed a band corresponding to the germline arrangement of the gene. In samples from a patient with a t(1;11)(q32;q23), and another with a t(11;14)(q23;q32), no rearrangements were detected by FISH or Southern blot analysis.
In one of the three cases with unknown partners, FISH detected a deletion of one copy of MLL, whereas Southern blotting showed the germline band. In the sample from a second patient, MLL was not rearranged, but three signals of the same size were seen in interphase nuclei after FISH analy-sis, indicating the presence of three copies of MLL. The cytogenetic study of this sample showed that there were two normal homologs of chromosome 11 plus an add(11)(q23) present. In the sample from a third patient, FISH showed three signals in interphase nuclei, and two adjacent signals on one homolog of chromosome 11 in metaphase spreads (Figure 3) , suggesting a duplication of the MLL gene. Southern blot analysis indicated only a germline arrangement for the MLL gene.
In cells from one patient, an inversion of the 11q23 band [inv(11)(p13q23)] was identified by cytogenetics. Results from FISH and Southern blot analysis indicated that the MLL gene was not rearranged.
11q23 deletion
Cytogenetic analysis indicated that 12 patients had 11q23 deletions; none had MLL gene translocations that were identified by FISH. Four of the 12 patients had T cell ALL, and eight patients had B-lineage ALL. FISH and Southern blot analysis indicated normal MLL gene arrangement in samples from three of the four patients with T cell ALL. Cytogenetic analysis from one of these patients showed that the cells were tetraploid, and FISH identified four signals, indicating the presence of four copies of chromosome 11. A deletion of one allele of the MLL gene was observed in cells from a fourth patient.
Among four patients with B-lineage ALL, FISH detected a deletion of one copy of MLL, whereas FISH showed that the other four patients had two copies of the gene. Among the patients with 11q23 deletions, five of 12 (42%) had a deleted MLL gene (allele) and seven (58%) had a breakpoint distal to the MLL gene. Southern blot analysis indicated that all 12 patients with an 11q23 deletion had a germline band of the MLL gene.
Figure 3
Metaphase showing a duplication of MLL gene by FISH. Chromosome 11 is hybridized with the biotin-labeled centromeric probe (green). A small arrow indicates the duplication of MLL gene (hybridized with the digoxigenin-labeled MLL probe). The normal MLL gene is also identified (big arrow).
Analysis of the MLL gene in children with AML
Twenty-five patients were evaluated by conventional cytogenetic, FISH, and Southern blot analyses. Nineteen patients were evaluated at the time of diagnosis and six were studied at the time of relapse. Eleven patients had a t(9;11), five had a t(11;19), and nine had translocations of 11q23 with variable partners. The results from the cytogenetic, FISH, and Southern blot analyses are summarized in Table 2 .
t(9;11)(p22;q23)
Of the 11 patients with AML who had a t(9;11), two were evaluated at the time of relapse: one had a conversion from ALL to AML, and the other patient had rhabdomyosarcoma at the time of diagnosis and developed AML as a secondary malignancy at the time of relapse. Four patients had a simple t(9;11) translocation, whereas two had complex translocations: t(5;9;11)(q23;p22;q23), and t(7;9;11)(p15;p22;q23). These three-way translocations in patients with leukemia have not been previously reported. The other five patients had additional abnormalities. In only one case was a discrepancy between the results from the Southern blot and FISH analyses observed: FISH showed two normal signals, whereas Southern blot analysis showed a MLL gene rearrangement.
t(11;19)(q23;p13)
Four of the five patients with a t (11;19) , had breakpoints at 19p13.1, and one had a breakpoint at 19p13.3. One patient had the following karyotype: 48,XX,+del(1)(p22),t(11;19) (q23;p13.1), +16 [6] . FISH showed that the MLL gene was translocated not only to 19p13.1, but also to the del(1)(p22) and 16p11.2, forming a der(1)t(1;11)(p22;q23) and der(16)t(11;16)(q23;p11.2) respectively (Figure 4) . The 1p22 and 16p11.2 regions have not been previously reported to be fusion partners for the MLL gene. The initial event may have been the rearrangement of the MLL gene with chromosome 19, and the rearrangements with 1p22 and 16p11.2 followed. MLL gene rearrangements were found in samples from all five patients with t(11;19) by FISH and Southern blot analysis.
t(11q23; variable)
The known partner chromosomal breakpoints for four of the nine cases of t(11q23;variable) included 1q21 (n = 2), and 6q27 (n = 2). Chromosomal regions of unknown origin were found on 11q23 in samples from two patients, whereas three patients had a complex karyotype involving 11q23.
Rearrangements of the MLL gene were detected by FISH and Southern analysis in all patients with AML and with 11q23 variant partners except one patient. This case had a complex karyotype involving one chromosome 11 homolog with two translocations: t(10;11)(p11.2;q23) and t(11;16)(q23;q22). The MLL gene rearrangement was detected by Southern blot analysis, but not by FISH. However, in the other two patients with complex karyotypes [(t(7;11) (p15;q23),ins(10;11)(p12;q22q23) and t(11;11)(q13;q23)], MLL gene rearrangements were detected by both FISH and Southern analysis.
Samples from two of the nine cases were studied at the time of relapse. One of the patients had the karyotype: The complex translocations included: t(7;11)(p15;q23),ins(10;11)(p12;q22q23); t(10;11)(p11.2;q23),t(11;16)(q23;q22) and t(11;11)(q13;q23). d Five signals were observed in cells from one patient; in addition to the t(11;19), two signals were identified on new breakpoints (1p22 and 16p11.2).
e MLL gene moved to der(20) but was not rearranged.
Figure 4
Metaphase demonstrating the FISH signals observed in a patient with AML and with a t(11;19)(q23;p13.1), a der(1)(1;11)(p22;q23), and a der(16)t(11;16) (q23;p11.2). The five signals were from the normal chromosome 11 (long arrow), the abnormal chromosome 11 (small arrow), the der(19)t(11;19) (open arrow), the der(16)t(11;16) (arrowhead), and the der(1)t(1;11) (medium arrow). 49 ,XY,+i(7)(q10),+8,add(11)(q23),der(20)t(11;20)(q13;q13.1),+ add(21)(p11.2) [19] /46,XY [1] . In the sample taken from this patient, FISH did not identify a MLL gene rearrangement, but detected the insertion of MLL gene on the der (20) . Southern blotting detected a germline band. The second patient had a t(11;16)(q23;q24) as the sole abnormality at the time of diagnosis, and at the time of relapse multiple chromosomal abnormalities including a t(11;11)(q13;q23) were identified by conventional cytogenetics. However, t(11;16) was not observed at the time of relapse. Both FISH and Southern blotting detected the MLL gene rearrangement.
In summary, among samples from 25 patients with AML, only two discrepancies in the results from FISH and Southern blot analyses were observed.
Discussion
A variety of chromosomal abnormalities involving chromosome 11q23 have been identified in patients with hematologic malignancies. 12 The majority of these abnormalities are translocations; the most frequently observed translocations include t(4;11), t(6;11), t(9;11), and t (11;19) . In infants with ALL, 11q23 abnormalities indicate a poor prognosis. 29, [36] [37] [38] [39] 57, 58 However, in children who have both ALL, and 11q23 abnormalities not involving MLL have a more favorable outcome. 34 Therefore, rapid and efficient detection of MLL rearrangements in patients with 11q23 abnormalities is important in determining the strategy for treating the disease.
In the present study, we evaluated patients with acute leukemia and with chromosomal aberrations at 11q23, to determine MLL gene rearrangements by FISH and Southern blot analysis. Among patients with ALL, MLL rearrangements were detected in 23 of 42 cases (54.8%) by both methods. In addition, in one patient a probable duplication of MLL and in another patient three copies of the gene were observed. FISH also identified deletions of one MLL allele in seven of the 42 cases (16.7%). MLL rearrangements were found in 22 of 25 cases (88%) of AML by FISH and in 24 and 25 (96%) by Southern blot analysis. Thus, of the 67 patients with acute leukemia, 47 patients (70%) had a rearranged MLL gene that was detected by Southern blot analysis and 45 (67%) had a rearranged MLL gene detected by FISH.
A novel finding seen in one of our patients with ALL and an add(11)(q23) found by cytogenetics, had a probable duplication of the MLL gene that was only identified by FISH (Figure 3) . Recently, similar duplications have been observed by FISH in two adult patients with AML. 11 Most partial tandem duplications of the MLL gene have been detected in adult patients with AML by Southern blot analysis; 26, 27, [59] [60] [61] [62] [63] [64] duplications have also been found in healthy persons. 65 Partial duplication of MLL in patients with ALL have not yet been previously reported. Further studies are needed to evaluate the type of duplication involved in this case.
In our previous study, 34 Southern blotting did not detect any MLL gene rearrangements in 14 children who had both ALL and deletions of 11q23. The present study includes seven patients from the previous study and five new patients with ALL and with 11q23 deletions. It is unclear why we identified a relatively large number of ALL with a deletion at 11q23 by conventional cytogenetic methods as compared with the numbers of cases identified by other laboratories. Perhaps the large number of pediatric cases studied at our institution, our direct method of harvesting, and the expertise of our cytogenetic technologists in the detailed evaluation of chromosomes of rather poor morphology may have contributed to the larger number of 11q23 deletions that we identified.
Occasionally Two discrepancies in the results from FISH and Southern blotting were observed in the study of patients with AML. In both cases, Southern blot analysis detected the MLL gene rearrangement, whereas FISH did not. According to the manufacturer, the probe lacks 3Ј sequence, and rearrangements where the breaks are in the 3Ј region of the MLL gene could not be detected by this probe. In these two patients where FISH did not identify the rearrangement, the break likely occurred in the 3Ј region of the MLL gene. It has been reported that breaks in the 3Ј region of MLL are observed in 20% of cases of acute leukemia. 70 However, in the present study FISH could not detect MLL rearrangements in only 3% (2/67) of the patients. The previously reported frequency of 20% may be overestimated.
A comprehensive review of the published reports describing different 11q23 abnormalities showed discrepancies in the results obtained by cytogenetic analyses, FISH, and other molecular methods in the detection of t(6;11), 71 69 In part, the conflicting findings may have resulted from different laboratories using different probes for FISH and Southern blotting analysis.
In contrast to the results from our study of patients with ALL, no deletions or duplications of the MLL gene were detected by FISH in our patients with AML. Interestingly, four of the 25 (16%) patients with AML had complex translocations involving the MLL gene rearrangement. The three-way translocations that have not been previously reported include t(5;9;11)(q23;p22;q23) and t(7;9;11)(p15;p22;q23).
Identification of two new partner breakpoints at 1p22 and 16p11.2 involved with the MLL gene rearrangement in a child with AML and a t(11;19) was also a significant finding of the present study. In this patient with AML, the primary event likely was a t (11;19) and additional translocations involving 11q23 and these unreported breakpoints (1p22 and 16p11.2) were probably a secondary event. The 1p22 band has been reported to be a partner breakpoint of 11q23 in a patient with ALL, 74 but it has not previously been shown to be involved in any rearrangements with the MLL gene and has not been reported in patients with AML.
Because of the variety of MLL gene rearrangements and the effectiveness of FISH in analyzing such rearrangements, as demonstrated in this large series, we recommend that FISH be a part of the diagnostic work-up of patients with ALL or AML when an 11q23 abnormality is detected by conventional cytogenetic methods. In a very short time (less than 24 h) and with a very limited amount of material, FISH can provide crucial diagnostic and prognostic information. In summary, FISH should be used for the rapid screening of MLL gene rearrangements and Southern blot analysis should be used for the definitive assessment of the MLL gene status.
